ADVANCED DRUG FORMULATION DESIGN TO OPTIMIZE THERAPEUTIC OUTCOMES
By Roberr O. Williams III, David R. Taft and Jason T. McConville
Description:
Advanced Drug Formulation Design to Optimize Therapeutic Outcomes demonstrates how modern compound designs and conveying technologies crapper be utilised to meliorate take effectualness and communication outcomes in portion therapeutic categories or disease states.
This aggregation discusses nanoparticle systems for cancer treatments, and also presents selection bounds immono-regulation agents for surgery and the topical targeting of drugs, especially poorly liquid solvable drugs to wage enhanced therapeutic outcomes. In addition, it highlights areas of therapy display the most prospect for transformation in clinical outcomes via modern compound design.
Advanced Drug Formulation Design to Optimize Therapeutic Outcomes demonstrates how modern compound designs and conveying technologies crapper be utilised to meliorate take effectualness and communication outcomes in portion therapeutic categories or disease states.
This aggregation discusses nanoparticle systems for cancer treatments, and also presents selection bounds immono-regulation agents for surgery and the topical targeting of drugs, especially poorly liquid solvable drugs to wage enhanced therapeutic outcomes. In addition, it highlights areas of therapy display the most prospect for transformation in clinical outcomes via modern compound design.
Features:
*Addresses numerous modern compound and conveying technologies, including mucoadhesion, chronopharmaceutical conveying finished sharp conveying devices, targeted nanoparticle systems, and modern solubilization technologies with liposomal conveying
*Covers field therapeutic categories much as communicable disease, cancer, system disorders, and secretor disorders
*Includes pre-clinical or clinical evidence, display an enhanced therapy achieved with modern compound organisation
*Discusses difficult-to-treat tumors requiring therapy agents to transfer the murder mentality barrier, which is of portion welfare for rising the coverall effectualness of much drugs with nonindulgent side-effects when administered in broad doses.
Download Links:
Or
